The Recall Desk

Manufacturer

Forest Pharmaceuticals Inc

6 recalls in our database name Forest Pharmaceuticals Inc as the manufacturing or recalling firm.

What the numbers show

Total
6
Critical
0
Severe
0
Most recent
2014-10-29

Of the 6 recalls from Forest Pharmaceuticals Inc we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 0 (0%) are Severe.

About this listing

The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.

Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.

1–6 of 6

  • ModerateFDA (Drugs)·D-0036-2015·2014-10-29

    Forest Pharmaceuticals Recalls Bystolic Tablets for Dissolution Failure

    Forest Pharmaceuticals is recalling Bystolic (nebivolol) 20 mg tablets because they failed a dissolution specification at a 6-month stability time point.

    Product
    Bystolic (nebivolol) tablets, 20 mg/tablet, packaged as 7 tablets/bottle/carton, and 12 bottles/trays, Professional Sample, Rx only, Forest Pharmaceuticals, Inc., St. Louis, MO. --- NDC 0456-1420-07
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1412-2014·2014-07-09

    Forest Pharmaceuticals Recalls Bystolic Tablets for Dissolution Failure

    Forest Pharmaceuticals is recalling Bystolic (nebivolol) 20 mg tablets because they failed stage III dissolution testing. The recall affects 92,544 bottles distributed nationwide.

    Product
    Bystolic (nebivolol) tablets, 20 mg/tablet. 7 Tablet Professional Sample Bottle, Rx Only. Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, Missouri 63045. NDC 0456-1420-07.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1348-2014·2014-05-28

    Forest Pharmaceuticals Recalls Bystolic Tablets for Dissolution Failures

    Forest Pharmaceuticals is voluntarily recalling one lot of Bystolic (nebivolol hydrochloride) tablets because dissolution test results failed to meet specifications.

    Product
    BYSTOLIC — BYSTOLIC (NEBIVOLOL HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1064-2014·2014-02-12

    Forest Pharmaceuticals Recalls Namenda XR Capsules for Dissolution Failures

    Forest Pharmaceuticals is recalling 3,950 packs of Namenda XR titration packs because they failed stability dissolution testing.

    Product
    Namenda XR (memantine HCl), titration pack (7 mg, 14 mg, 21 mg and 28 mg) extended release capsules, packaged in 28-capsule, 4 week, titration pack,Rx only, Forest Pharmaceuticals Inc., St. Louis, MO 63045 NDC 0456-3400-29.
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-1063-2014·2014-02-12

    Forest Pharmaceuticals Recalls Namenda XR Capsules for Dissolution Failures

    Forest Pharmaceuticals is recalling 156 bottles of Namenda XR 7 mg capsules because they failed stability dissolution testing. The affected product was distributed nationwide and in Puerto Rico.

    Product
    Namenda XR (memantine HCl), 7 mg extended release capsules, 30-count bottle, Rx only, Forest Pharmaceuticals Inc., St. Louis, MO 63045, NDC 0456-3407-33
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-1065-2014·2014-02-12

    Forest Pharmaceuticals Recalls Namenda XR Sample Packs for Dissolution Failures

    Forest Pharmaceuticals is recalling Namenda XR sample packs because they failed stability dissolution testing. The affected lots were distributed nationwide and in Puerto Rico.

    Product
    Namenda XR (memantine HCl), sample pack, 28 mg, extended release capsules, packaged in 5-count sample packs, Rx only, Forest Pharmaceuticals Inc., St. Louis, MO 63045 NDC 0456-3428-05.
    Category
    Drug
    Distribution
    Distributed nationwide